Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101


Induction, binding specificity and function of human ICOS.

Beier KC, Hutloff A, Dittrich AM, Heuck C, Rauch A, Büchner K, Ludewig B, Ochs HD, Mages HW, Kroczek RA.

Eur J Immunol. 2000 Dec;30(12):3707-17.


Molecular cloning and characterization of murine ICOS and identification of B7h as ICOS ligand.

Mages HW, Hutloff A, Heuck C, Büchner K, Himmelbauer H, Oliveri F, Kroczek RA.

Eur J Immunol. 2000 Apr;30(4):1040-7.


ICOS and CD28 reversely regulate IL-10 on re-activation of human effector T cells with mature dendritic cells.

Witsch EJ, Peiser M, Hutloff A, Büchner K, Dorner BG, Jonuleit H, Mages HW, Kroczek RA.

Eur J Immunol. 2002 Sep;32(9):2680-6.


ICOS cooperates with CD28, IL-2, and IFN-gamma and modulates activation of human naïve CD4+ T cells.

Mesturini R, Nicola S, Chiocchetti A, Bernardone IS, Castelli L, Bensi T, Ferretti M, Comi C, Dong C, Rojo JM, Yagi J, Dianzani U.

Eur J Immunol. 2006 Oct;36(10):2601-12.


A distinct role for ICOS-mediated co-stimulatory signaling in CD4+ and CD8+ T cell subsets.

Watanabe M, Hara Y, Tanabe K, Toma H, Abe R.

Int Immunol. 2005 Mar;17(3):269-78. Epub 2005 Jan 24.


Cutting edge: the related molecules CD28 and inducible costimulator deliver both unique and complementary signals required for optimal T cell activation.

Gonzalo JA, Delaney T, Corcoran J, Goodearl A, Gutierrez-Ramos JC, Coyle AJ.

J Immunol. 2001 Jan 1;166(1):1-5.


Roles of CD28, CTLA4, and inducible costimulator in acute graft-versus-host disease in mice.

Li J, Semple K, Suh WK, Liu C, Chen F, Blazar BR, Yu XZ.

Biol Blood Marrow Transplant. 2011 Jul;17(7):962-9. doi: 10.1016/j.bbmt.2011.01.018. Epub 2011 Mar 27.


Eminent role of ICOS costimulation for T cells interacting with plasmacytoid dendritic cells.

Janke M, Witsch EJ, Mages HW, Hutloff A, Kroczek RA.

Immunology. 2006 Jul;118(3):353-60.


Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4+ T cells.

McAdam AJ, Chang TT, Lumelsky AE, Greenfield EA, Boussiotis VA, Duke-Cohan JS, Chernova T, Malenkovich N, Jabs C, Kuchroo VK, Ling V, Collins M, Sharpe AH, Freeman GJ.

J Immunol. 2000 Nov 1;165(9):5035-40.


Opposing effects of ICOS on graft-versus-host disease mediated by CD4 and CD8 T cells.

Yu XZ, Liang Y, Nurieva RI, Guo F, Anasetti C, Dong C.

J Immunol. 2006 Jun 15;176(12):7394-401.


The CD28 related molecule ICOS: T cell modulation in the presence and absence of B7.1/2 and regulational expression in multiple sclerosis.

Wiendl H, Neuhaus O, Mehling M, Wintterle S, Schreiner B, Mitsdoerffer M, Wienhold W, Weissert R, Wessels J, Hartung HP, Weller M, Tolosa E, Melms A.

J Neuroimmunol. 2003 Jul;140(1-2):177-87.


The inducible costimulator (ICOS) is critical for the development of human T(H)17 cells.

Paulos CM, Carpenito C, Plesa G, Suhoski MM, Varela-Rohena A, Golovina TN, Carroll RG, Riley JL, June CH.

Sci Transl Med. 2010 Oct 27;2(55):55ra78. doi: 10.1126/scitranslmed.3000448.


Characterization of human inducible costimulator ligand expression and function.

Aicher A, Hayden-Ledbetter M, Brady WA, Pezzutto A, Richter G, Magaletti D, Buckwalter S, Ledbetter JA, Clark EA.

J Immunol. 2000 May 1;164(9):4689-96.


ICOS is critical for CD40-mediated antibody class switching.

McAdam AJ, Greenwald RJ, Levin MA, Chernova T, Malenkovich N, Ling V, Freeman GJ, Sharpe AH.

Nature. 2001 Jan 4;409(6816):102-5.


Impaired CD4 and CD8 effector function and decreased memory T cell populations in ICOS-deficient patients.

Takahashi N, Matsumoto K, Saito H, Nanki T, Miyasaka N, Kobata T, Azuma M, Lee SK, Mizutani S, Morio T.

J Immunol. 2009 May 1;182(9):5515-27. doi: 10.4049/jimmunol.0803256.


Interaction of B7RP-1 with ICOS negatively regulates antigen presentation by B cells.

Wahl P, Schoop R, Horan TP, Yoshinaga SK, Wüthrich RP.

Inflammation. 2003 Aug;27(4):191-200.


IFN-alpha beta promote priming of antigen-specific CD8+ and CD4+ T lymphocytes by immunostimulatory DNA-based vaccines.

Cho HJ, Hayashi T, Datta SK, Takabayashi K, Van Uden JH, Horner A, Corr M, Raz E.

J Immunol. 2002 May 15;168(10):4907-13.

Supplemental Content

Support Center